Navigation Links
Orexigen Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
Date:11/27/2013

SAN DIEGO, Nov. 27, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the 25th Annual Piper Jaffray Healthcare Conference in New York. The presentation is scheduled for Tuesday, December 3rd  at 11:00 a.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave, which the Company is evaluating in the Light Study, a cardiovascular outcomes trial being conducted under a Special Protocol Assessment (SPA) with the FDA. Based on successful results of the Light Study, the Company plans to resubmit the Contrave NDA to the FDA with potential approval by June 2014.The Company's other product candidate, Empatic, has completed Phase 2 clinical trials. Further information about the Company can be found at www.orexigen.com. Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

BrewLife(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen Announces Successful Interim Analysis of Contrave Light Study
2. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
3. Orexigen Therapeutics Reports Business and Financial Results for the Third Quarter Ended September 30, 2013
4. Orexigen and Takeda Announce Multiple Contrave Data Presentations at the ObesityWeek Meeting in Atlanta
5. Orexigen Therapeutics Enters Into Agreement with Sanofi to Manufacture Contrave for Territories Outside North America
6. A Balanced Risk-Benefit Profile Will Propel Orexigen/Takedas Contrave to Become the Most Widely Used Emerging Therapy for the Treatment of Obese and Overweight Patients
7. Orexigen Therapeutics Announces Date of Third Quarter 2013 Financial Results Conference Call and Upcoming Presentation at Credit Suisse Healthcare Conference
8. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
9. Orexigen Therapeutics Announces European Filing Strategy and Reports Business and Financial Results for the Second Quarter Ended June 30, 2013
10. Orexigen Therapeutics to Host Second Quarter 2013 Financial Results Conference Call and Webcast
11. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Concord Medical Services Holdings ... specialty hospital management solution provider and operator of the largest ... China , today announced it will release its financial ... closes on August 17, 2015. Management will hold ... at 8:00 a.m. EDT on August 18, 2015 (8:00 p.m. ...
(Date:8/4/2015)... Aug. 4, 2015 Organovo Holdings, Inc. ... focused on delivering scientific and medical breakthroughs using ... has hired Paul Gallant as its ... and product business. Mr. Gallant has more than 20 ... drug discovery industry, most recently serving as chief ...
(Date:8/4/2015)... , Aug. 4, 2015  ContraVir Pharmaceuticals, ... focused on the development and commercialization of targeted ... Chief Executive Officer, will present live at VirtualInvestorConferences.com ... August 6, 2015 TIME: 12:15PM EDT LINK: ... a live, interactive online event where investors are ...
Breaking Medicine Technology:Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 2Organovo Holdings, Inc. Appoints Paul Gallant as General Manager 3ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 2ContraVir to Webcast Investor Presentation on August 6: VirtualInvestorConferences.com 3
(Date:8/5/2015)... ... 05, 2015 , ... Stelari introduces their new collection, The Earth’s Song, inspired ... line, The Earth’s Song. Combining fashion and activewear, Stelari’s new collection let’s you take ... Australian Outback, this collection is sure to make the spirit seeker swoon with prints ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... ... critical research funding, as well as awareness, education and support in order to ... Brain Aneurysm Foundation proudly announces this year it has awarded the most ...
(Date:8/4/2015)... ... ... MONTICELLO, Fla. – After completing 2,400 hours in the Clinical Pastoral Education Programs ... clinician allowed Dr. Barbara Thomas-Reddick to gain the skills and the know-how ... friends and staff, and she was able to witness after leaving the patients’ bedside, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Statement by ... applauds the introduction of the Mental Health Reform Act of 2015 by ... comprehensive mental health reform a reality in America. , “This legislation and ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... uses Cloud innovation to consolidate oncology patient assistance programs. Through a secure web ... of access. assistPoint is an enterprise level, cloud-based application and workflow solution. This ...
Breaking Medicine News(10 mins):Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:assistPoint.com Web Site Launched 2
... , ... a company dedicated to disseminating information on dentistry,s role in the recognition and management of ... web site for the second month in a row. , ... New York, NY (PRWEB) July 31, 2009 -- Snoring Isn,t ...
... , WHITE PLAINS, N.Y., July 30 The ... University of Chicago, a pioneer in demonstrating that cancer is a ... President Barack Obama will award the Medals of Freedom, the nation,s ... Aug. 12, 2009. , , Dr. Rowley is ...
... , , , ... and Consumer Product Safety, The Pew Charitable Trusts: , , ... and strengthen the nation,s food safety system. This historic action takes a ... of their food. , , "Foodborne disease kills one ...
... Calls on Senate to Follow Suit , , ... commended the members of the United States House of Representatives for passing ... passed the House by a vote of 283-142. , , ... an important milestone," said Ms. Bailey. "This legislation will strengthen our ...
... , BOISE, Idaho, July 30 ... named John Stellmon, president of Regence BlueShield of Idaho, to ... In his new expanded role, effective August 1, ... health management programs. He will also oversee Pharmacy Services, Network ...
... implemented, expert says , THURSDAY, July 30 (HealthDay ... lead to reduced use of palliative care, Belgian researchers ... Group in Brussels also found that dying patients who ... life were more likely to choose euthanasia or physician-assisted ...
Cached Medicine News:Health News:SnoringIsntSexy.com Tops 21,000 Site Visits for Second Month in a Row 2Health News:Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom 2Health News:GMA Applauds U.S. House for Passage of Landmark Food Safety Bill 2Health News:Regence BlueShield of Idaho Announces Executive Changes 2Health News:Regence BlueShield of Idaho Announces Executive Changes 3Health News:Euthanasia, Palliative Care Work in Unison in Belgium 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: